Recent news on Tamoxifen Citrate

Cytogen Reports Publication Validating the Utility of its ...  -  May 23, 2007
Business Wire (press release),...(tamoxifen citrate) is the first liquid hormonal therapy approved in the US for the treatment of breast cancer in adjuvant and metastatic settings.

Decision Imminent in Tamoxifen Petition on AstraZeneca, Barr ...  -  Mar 16, 2007
Seeking Alpha,...or not to grant certiorari in In Re: Tamoxifen Citrate Antitrust Litigation, the latest "reverse payment" settlement case to be presented to the Court.

Soltamox is available in the US through Cytogen Corporation (Photo ...  -  Mar 15, 2007
Genetic Engineering News (press release),SOLTAMOX, the only liquid form of tamoxifen citrate, is an alternative for women who require tamoxifen therapy. SOLTAMOX may be an attractive option for

Supreme Court seeks government views in tamoxifen patent settlement  -  Mar 19, 2007
MarketWatchThe case is Tamoxifen Citrate Antitrust Litigation v. Barr Laboratories, 06-830. The Solicitor General's office will submit its brief later in 2006 and then

Cytogen Reports Fourth Quarter and Full Year 2006 Financial Results  -  Mar 1, 2007
PharmaLive.com (press release),..."First, we expanded our revenue opportunities with the in-licensing of two marketed therapeutic products, SOLTAMOX(TM) (tamoxifen citrate) and CAPHOSOL,

Cytogen Unveils New Oral Mucositis Education and Support Program ...  -  Mar 6, 2007
PharmaLive.com (press release),QUADRAMET(R) (samarium Sm-153 lexidronam), PROSTASCINT(R) (capromab pendetide), and SOLTAMOX(TM) (tamoxifen citrate) to the US oncology market.

Cytogen Unveils New Oral Mucositis Education and Support Program ...  -  Mar 6, 2007
Business Wire (press release),QUADRAMET ® (samarium Sm-153 lexidronam), PROSTASCINT ® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the US oncology market.

Cytogen Announces Initiation of NCI-Sponsored Phase 2 Clinical ...  -  Mar 1, 2007
PharmaLive.com (press release),PROSTASCINT(R) (capromab pendetide), and SOLTAMOX(TM) (tamoxifen citrate) to the US oncology market. QUADRAMET is approved for the treatment of pain in

Cytogen Announces Initiation of NCI-Sponsored Phase 2 Clinical ...  -  Mar 1, 2007
Business Wire (press release),QUADRAMET ® (samarium Sm-153 lexidronam injection), PROSTASCINT ® (capromab pendetide), and SOLTAMOX ™ (tamoxifen citrate) to the US oncology market.

Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled ...  -  Feb 27, 2007
NJBIZ,QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the US oncology market.

New Clinical Data for PROSTASCINT(R) and QUADRAMET(R) in Prostate ...  -  25 Feb 2007
FinanzNachrichten.de,QUADRAMET ® (samarium Sm-153 lexidronam injection), PROSTASCINT ® (capromab pendetide), and SOLTAMOX â„¢ (tamoxifen citrate) to the US oncology market.

Generic Drug Pacts Rile the FTC  -  Feb 22, 2007
New York Law Journal,The settlement in the Tamoxifen Citrate case allowed Barr Pharmaceuticals Inc. of Woodcliff Lake, NJ, to introduce a competing generic drug years before the

Steroids, The Truth  -  Jan 16, 2007
SportingNews.comA SERM such as clomiphene citrate and/or tamoxifen citrate (this is the primary PCT drug). * Human chorionic gonadotropin, hCG (this has become less common

Senate Committee Hears Arguments Regarding Reverse Payments  -  Jan 7, 2007
Patent Baristas,...consumer groups are now petitioning the Court to basically take up the same issue in the similar case In re: Tamoxifen Citrate Antitrust Litigation.

We heard an awful lot about the advent of biomarkers:  -  Dec 6, 2006
Drug Discovery & Development,Finally, the Court is expected by many to hear the Tamoxifen Citrate Antitrust Litigation case late in 2007. This is the case regarding the use of reverse

Cytogen Reports Third Quarter 2006 Financial Results  Nov 2, 2006
Savient Pharmaceuticals. In August 2006, Cytogen began introducing SOLTAMOX (tamoxifen citrate) to the US oncology market. During ... -MSN Money Breast cancer sufferers welcome PBS drugs  Oct 26, 2006
It will be available to patients who have already had a minimum of two years treatment with another breast cancer drug, tamoxifen citrate. ... -Melbourne Herald Sun, Read more  Nov 1, 2006
Aromasin® will be available for patients who have already had a minimum of two years treatment with another breast cancer drug, tamoxifen citrate. ... -SpiritIndia, US Court of Appeals Denies Rehearing Request in Dismissal of ...  Sep 18, 2006
Court of Appeals for the Second Circuit has denied the plaintiffs' petitions for rehearing and rehearing en banc in the Tamoxifen Citrate antitrust lawsuits. ... -Yahoo! News

Market Report -- In Play (BRL)  Sep 18, 2006
Barr Pharma: US court of appeals denies rehearing request in dismissal of Tamoxifen citrate antitrust lawsuits Co announces that the United States Court of ... -MSN Money

Barr:Appeals Court Denies Rehearing Request In Tamoxifen Suit  Sep 18, 2006
BRL) said Monday the US Court of Appeals for the Second Circuit has denied the plaintiffs' petitions for rehearing in the tamoxifen citrate antitrust lawsuits. ... -Easy Bourse (Communiqués de presse)

Barr: Appeals court denies rehearing in tamoxifen suit  Sep 18, 2006
Circuit. Barr launched its generic version of tamoxifen citrate, a drug for the treatment of breast cancer, in February 2003. Shares ... -Centre Daily Times

(PRN) - Total Parts Plus Introduces Parts Plus Content Complete .. ...  Sep 18, 2006
October ... [+. PRN) - US Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits ... [+. ... -Bolsamania.com

(PRN) - NASD DR Mediation Prices Reduced During 'Settlement Month' ...  Sep 18, 2006
...(PRN) - US Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits ... [+. PRN) - Pace and ... -Bolsamania.com

Combination of High Dose QUADRAMET(R) and Chemotherapy Shows ...  Sep 18, 2006
...injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In-111 capromab pendetide, and SOLTAMOX(TM) (tamoxifen citrate, oral solution ... -Yahoo! News

Prescription of Tamoxifen for Breast Cancer Prevention by Primary ...  -  Nov 13, 2006
Archives of Internal MedicineBackground Although tamoxifen citrate has been approved for primary reduction of breast cancer risk since 1998, little is known about the prescription of

We heard an awful lot about the advent of biomarkers:  -  Dec 6, 2006
Drug Discovery & Development,Finally, the Court is expected by many to hear the Tamoxifen Citrate Antitrust Litigation case late in 2007. This is the case regarding the use of reverse

Cytogen Corporation and Mayor Rudy Giuliani to Ring in Prostate ...  29 Aug 2006
...injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In-111 capromab pendetide, and SOLTAMOX(TM) (tamoxifen citrate, oral solution ... -Yahoo! News

Cytogen Launches SOLTAMOX(TM), First Oral Liquid Formulation of ...  Aug 16, 2006
16 /PRNewswire-FirstCall/ -- Cytogen Corporation (Nasdaq: CYTO - News) today announced that SOLTAMOX(TM) (tamoxifen citrate, oral solution 10mg/5mL), the first ... -Yahoo! News

Cytogen Launches Soltamox, First Oral Liquid Formulation of ...  Aug 16, 2006
PRINCETON, NJ, August 16, 2006 /PRNewswire-FirstCall/ -- Cytogen Corporation today announced that SOLTAMOX(TM) (tamoxifen citrate, oral solution 10mg/5mL), the ... -PharmaLive.com

Cytogen Launches SOLTAMOX(TM), First Oral Liquid Formulation of ...  Aug 16, 2006
16 /PRNewswire-FirstCall/ -- Cytogen Corporation today announced that SOLTAMOX(TM) (tamoxifen citrate, oral solution 10mg/5mL), the first liquid form of the ... -Boursorama

Cytogen Launches First Oral Liquid Formulation of Hormonal Therapy ...  Aug 17, 2006
PRINCETON, NJ -- August 17, 2006 -- Cytogen Corporation announced that Soltamox(TM) (tamoxifen citrate, oral solution 10mg/5mL), the first liquid form of the ... -DG News

Aromatase Inhibitors Declared Superior To Tamoxifen In The ...  Aug 3, 2006
NOLVADEX® (tamoxifen citrate) is approved for the adjuvant treatment of node-positive and node-negative early breast cancer in postmenopausal women following ... -Medical News Today

Aromatase Inhibitors Declared Superior to Tamoxifen in the ...  Aug 1, 2006
About Tamoxifen NOLVADEX(R) (tamoxifen citrate) is approved for the adjuvant treatment of node-positive and node-negative early breast cancer in postmenopausal ... -PR Newswire

Savient Pharmaceuticals Reports Second Quarter and First Half 2006 ...  Aug 8, 2006
Finalized the US marketing rights for Soltamox(TM) (tamoxifen citrate) with Cytogen Corporation granting exclusive marketing rights for an upfront licensing ... -Finanzen.net



Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
...injection), PROSTASCINT(R) (capromab pendetide) kit for the preparation of Indium In-111 capromab pendetide and SOLTAMOX(TM) (tamoxifen citrate) in the United ... - Genetic Engineering News

Cytogen Corporation to Present at the Rodman & Renshaw 3rd Annual ...  May 9, 2006
...injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In-111 capromab pendetide, and SOLTAMOX(TM) (tamoxifen citrate) in the United ... - Yahoo! News

Cytogen Reports First Quarter 2006 Financial Results  May 8, 2006
...finalized an exclusive distribution agreement for SOLTAMOX (tamoxifen citrate), a cytostatic estrogen receptor antagonist and the first oral liquid hormonal ... - Yahoo! News

Cytogen and Savient Finalize Exclusive Distribution Agreement for ...  Apr 24, 2006
SVNT - News) announced today the execution of a distribution agreement granting Cytogen exclusive marketing rights for SOLTAMOX(TM) (tamoxifen citrate) in the ... - Yahoo! News

New licensing and development agreements.  Apr 26, 2006
The deal gives Cytogen exclusive US marketing rights Soltamox (tamoxifen citrate) a hormone therapy for cancer. Soltamox is a liquid product taken orally. ... - PharmExec.com

Cytogen Selling PSMA Joint Venture Share To Progenics  Apr 24, 2006
The deal gives Cytogen exclusive US marketing rights for Soltamox (tamoxifen citrate), a cytostatic estrogen receptor antagonist, which is the first oral ... - BioWorld Online (subscription)

Cytogen to distribute Soltamox in USA  Apr 25, 2006
...have finalized a distribution agreement granting the former exclusive marketing rights for its breast cancer drug, Soltamox (tamoxifen citrate), in the ... - Therapeutics Daily (subscription)





Cytogen Reports Fourth Quarter and Full Year 2005 Financial ...  Feb 23, 2006
...of a binding letter of intent to negotiate a definitive agreement granting Cytogen exclusive marketing rights for SOLTAMOX(TM) (tamoxifen citrate) in the ... - MSN Money

ETS delaying launch of revised examination  09 Feb 2006
...and Savient Pharmaceuticals yesterday announced plans to give Cytogen exclusive marketing rights to Savient's Soltamox (tamoxifen citrate) in the United States ... - Trenton Times

Cytogen and Savient Sign Letter of Intent for Marketing of ...  Feb 8, 2006
...of a binding letter of intent to negotiate a definitive agreement granting Cytogen exclusive marketing rights for SOLTAMOX(TM) (tamoxifen citrate) in the ... - PR Newswire

Phosphagenics initiates anti-cancer compound animal trials  Jan 25, 2006
...buoyed on by this encouraging preliminary data, which also claimed a significant advantage over the anti-breast cancer drug Nolvadex (tamoxifen citrate). ... - BiopharmaReporter.com

FTC chief concerned about drug patent deals  Jan 11, 2006
The patent settlement challenged in that case involved AstraZeneca's Tamoxifen Citrate, the most widely prescribed drug for breast cancer treatment. ... - Reuters

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional